The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 03, 2021

Filed:

Dec. 29, 2016
Applicant:

Microvax, Llc, Warrenton, VA (US);

Inventors:

Yucheng Tang, San Diego, CA (US);

Albert B. Deisseroth, Potomac, MD (US);

Assignee:

MicroVAX, LLC, Warrenton, VA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/145 (2006.01); A61K 39/39 (2006.01); A61K 39/12 (2006.01); C07K 14/005 (2006.01); C07K 14/705 (2006.01); A61K 39/00 (2006.01); A61K 39/385 (2006.01);
U.S. Cl.
CPC ...
A61K 39/145 (2013.01); A61K 39/12 (2013.01); A61K 39/39 (2013.01); C07K 14/005 (2013.01); C07K 14/70575 (2013.01); A61K 39/385 (2013.01); A61K 2039/5256 (2013.01); A61K 2039/53 (2013.01); A61K 2039/545 (2013.01); A61K 2039/55 (2013.01); A61K 2039/575 (2013.01); A61K 2039/585 (2013.01); A61K 2039/6031 (2013.01); C07K 2319/02 (2013.01); C07K 2319/06 (2013.01); C07K 2319/33 (2013.01); C12N 2710/10034 (2013.01); C12N 2710/10043 (2013.01); C12N 2710/10343 (2013.01); C12N 2710/20034 (2013.01); C12N 2760/16122 (2013.01); C12N 2760/16134 (2013.01);
Abstract

Provided are methods of generating an immune response to any of various antigens including foreign antigens such as infectious agent antigens. In general, the method comprises administering an expression vector encoding a transcription unit encoding a secretable fusion protein, the fusion protein containing the foreign antigen and CD40 ligand and also administering the encoded fusion protein. In another approach, an immune response to the foreign antigen is elicited using the encoded fusion protein without administering the vector. The invention methods may be used to immunize an individual against an infectious agent such as influenza virus. Methods of obtaining an immune response in older individuals also is described.


Find Patent Forward Citations

Loading…